BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

962 related articles for article (PubMed ID: 16197336)

  • 1. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
    Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
    Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helper role of NK cells during the induction of anticancer responses by dendritic cells.
    Kalinski P; Giermasz A; Nakamura Y; Basse P; Storkus WJ; Kirkwood JM; Mailliard RB
    Mol Immunol; 2005 Feb; 42(4):535-9. PubMed ID: 15607810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.
    Mailliard RB; Son YI; Redlinger R; Coates PT; Giermasz A; Morel PA; Storkus WJ; Kalinski P
    J Immunol; 2003 Sep; 171(5):2366-73. PubMed ID: 12928383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
    Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
    J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.
    Nguyen-Pham TN; Yang DH; Nguyen TA; Lim MS; Hong CY; Kim MH; Lee HJ; Lee YK; Cho D; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Lee JJ
    Cell Mol Immunol; 2012 Jan; 9(1):45-53. PubMed ID: 21822297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
    Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bidirectional crosstalk between human dendritic cells and natural killer cells.
    Wehner R; Dietze K; Bachmann M; Schmitz M
    J Innate Immun; 2011; 3(3):258-63. PubMed ID: 21411969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
    Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
    Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
    Bödder J; Zahan T; van Slooten R; Schreibelt G; de Vries IJM; Flórez-Grau G
    Front Immunol; 2020; 11():631713. PubMed ID: 33679726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk.
    Saïdi H; Melki MT; Gougeon ML
    PLoS One; 2008; 3(10):e3601. PubMed ID: 18974890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells.
    Capobianco A; Rovere-Querini P; Rugarli C; Manfredi AA
    Int J Cancer; 2006 Dec; 119(12):2861-9. PubMed ID: 16998790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy.
    Calmeiro J; Mendes L; Duarte IF; Leitão C; Tavares AR; Ferreira DA; Gomes C; Serra J; Falcão A; Cruz MT; Carrascal MA; Neves BM
    Front Immunol; 2020; 11():593363. PubMed ID: 33613517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.
    Ferlazzo G; Tsang ML; Moretta L; Melioli G; Steinman RM; Münz C
    J Exp Med; 2002 Feb; 195(3):343-51. PubMed ID: 11828009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
    Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
    J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.
    Srivastava RM; Lee SC; Andrade Filho PA; Lord CA; Jie HB; Davidson HC; López-Albaitero A; Gibson SP; Gooding WE; Ferrone S; Ferris RL
    Clin Cancer Res; 2013 Apr; 19(7):1858-72. PubMed ID: 23444227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
    Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
    Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.
    Arina A; Murillo O; Dubrot J; Azpilikueta A; Alfaro C; Pérez-Gracia JL; Bendandi M; Palencia B; Hervás-Stubbs S; Melero I
    Expert Opin Biol Ther; 2007 May; 7(5):599-615. PubMed ID: 17477799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.
    van Beek JJ; Wimmers F; Hato SV; de Vries IJ; Sköld AE
    Crit Rev Immunol; 2014; 34(6):517-36. PubMed ID: 25597314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.